No Data
No Data
Express News | BioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product Family
BioCardia Announces Commercial Availability of Morph DNA Steerable Introducer Product Family
Express News | BioCardia Inc - Final Data From Cardiamp Heart Failure Trial Expected Q1 2025
Express News | BioCardia Announces Positive Consultation With Japan Pmda on Cardiamp Cell Therapy for Ischemic Heart Failure
BioCardia Announces Positive Consultation With Japan PMDA on CardiAMP Cell Therapy for Ischemic Heart Failure
BioCardia Third Quarter 2024 Earnings: US$0.61 Loss per Share (Vs US$1.79 Loss in 3Q 2023)
Unlock the Full List